Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 8092 | 24.685 |
09:34 ET | 1980 | 24.62 |
09:36 ET | 500 | 24.62 |
09:38 ET | 1112 | 24.725 |
09:41 ET | 900 | 24.72 |
09:43 ET | 2999 | 24.68 |
09:45 ET | 100 | 24.66 |
09:48 ET | 12213 | 24.62 |
09:50 ET | 500 | 24.615 |
09:52 ET | 5755 | 24.52 |
09:54 ET | 3666 | 24.485 |
09:56 ET | 1284 | 24.43 |
09:57 ET | 1370 | 24.49 |
09:59 ET | 1569 | 24.5 |
10:01 ET | 3167 | 24.47 |
10:03 ET | 800 | 24.35 |
10:06 ET | 2127 | 24.36 |
10:08 ET | 6082 | 24.35 |
10:10 ET | 1402 | 24.38 |
10:12 ET | 2900 | 24.35 |
10:14 ET | 400 | 24.31 |
10:15 ET | 5061 | 24.345 |
10:17 ET | 4309 | 24.32 |
10:19 ET | 1111 | 24.31 |
10:21 ET | 9897 | 24.33 |
10:24 ET | 3311 | 24.36 |
10:26 ET | 6818 | 24.34 |
10:28 ET | 2201 | 24.365 |
10:30 ET | 4172 | 24.38 |
10:32 ET | 5732 | 24.32 |
10:33 ET | 1554 | 24.31 |
10:35 ET | 4567 | 24.3192 |
10:37 ET | 3099 | 24.27 |
10:39 ET | 2810 | 24.31 |
10:42 ET | 5270 | 24.31 |
10:44 ET | 1660 | 24.3265 |
10:46 ET | 900 | 24.335 |
10:48 ET | 2740 | 24.365 |
10:50 ET | 6428 | 24.39 |
10:51 ET | 7325 | 24.36 |
10:53 ET | 1200 | 24.35 |
10:55 ET | 4173 | 24.38 |
10:57 ET | 1064 | 24.37 |
11:00 ET | 600 | 24.38 |
11:02 ET | 2431 | 24.4 |
11:04 ET | 1300 | 24.41 |
11:06 ET | 4052 | 24.41 |
11:08 ET | 1100 | 24.4 |
11:09 ET | 3738 | 24.37 |
11:11 ET | 5671 | 24.425 |
11:13 ET | 2854 | 24.44 |
11:15 ET | 2325 | 24.42 |
11:18 ET | 2364 | 24.445 |
11:20 ET | 5599 | 24.45 |
11:22 ET | 1247 | 24.45 |
11:24 ET | 2142 | 24.445 |
11:26 ET | 767 | 24.46 |
11:27 ET | 4789 | 24.45 |
11:29 ET | 3125 | 24.45 |
11:31 ET | 37957 | 24.5 |
11:33 ET | 2679 | 24.46 |
11:36 ET | 3325 | 24.44 |
11:38 ET | 1898 | 24.37 |
11:40 ET | 4448 | 24.38 |
11:42 ET | 2701 | 24.38 |
11:44 ET | 11006 | 24.34 |
11:45 ET | 10259 | 24.35 |
11:47 ET | 2929 | 24.31 |
11:49 ET | 3700 | 24.31 |
11:51 ET | 2768 | 24.31 |
11:54 ET | 6808 | 24.315 |
11:56 ET | 100 | 24.31 |
11:58 ET | 4758 | 24.33 |
12:00 ET | 5151 | 24.37 |
12:02 ET | 2480 | 24.33 |
12:03 ET | 2373 | 24.31 |
12:05 ET | 1658 | 24.34 |
12:07 ET | 1154 | 24.38 |
12:09 ET | 806 | 24.39 |
12:12 ET | 1672 | 24.4199 |
12:14 ET | 6910 | 24.42 |
12:16 ET | 1153 | 24.42 |
12:18 ET | 2698 | 24.41 |
12:20 ET | 3911 | 24.42 |
12:21 ET | 400 | 24.43 |
12:23 ET | 1468 | 24.43 |
12:25 ET | 4289 | 24.42 |
12:27 ET | 2378 | 24.425 |
12:30 ET | 301 | 24.425 |
12:32 ET | 4021 | 24.405 |
12:34 ET | 3038 | 24.37 |
12:36 ET | 2145 | 24.39 |
12:38 ET | 1100 | 24.4 |
12:39 ET | 1100 | 24.41 |
12:43 ET | 2620 | 24.4297 |
12:45 ET | 434 | 24.42 |
12:48 ET | 4065 | 24.39 |
12:50 ET | 1430 | 24.38 |
12:52 ET | 2510 | 24.395 |
12:54 ET | 400 | 24.4 |
12:56 ET | 33763 | 24.475 |
12:57 ET | 6612 | 24.46 |
12:59 ET | 2454 | 24.43 |
01:01 ET | 5496 | 24.46 |
01:03 ET | 1115 | 24.45 |
01:06 ET | 2774 | 24.45 |
01:08 ET | 2001 | 24.46 |
01:10 ET | 1705 | 24.49 |
01:12 ET | 2400 | 24.515 |
01:14 ET | 4267 | 24.46 |
01:15 ET | 2433 | 24.445 |
01:17 ET | 854 | 24.43 |
01:19 ET | 18308 | 24.44 |
01:21 ET | 8197 | 24.465 |
01:24 ET | 2451 | 24.46 |
01:26 ET | 4109 | 24.44 |
01:28 ET | 500 | 24.44 |
01:30 ET | 2384 | 24.45 |
01:32 ET | 997 | 24.46 |
01:33 ET | 400 | 24.46 |
01:35 ET | 495 | 24.46 |
01:37 ET | 7815 | 24.42 |
01:39 ET | 900 | 24.415 |
01:42 ET | 1740 | 24.37 |
01:44 ET | 4156 | 24.39 |
01:46 ET | 1899 | 24.36 |
01:48 ET | 2198 | 24.39 |
01:50 ET | 200 | 24.39 |
01:51 ET | 17570 | 24.39 |
01:53 ET | 1282 | 24.38 |
01:55 ET | 1830 | 24.38 |
01:57 ET | 1779 | 24.33 |
02:00 ET | 2356 | 24.35 |
02:02 ET | 3655 | 24.37 |
02:04 ET | 5342 | 24.31 |
02:06 ET | 3628 | 24.33 |
02:08 ET | 300 | 24.33 |
02:09 ET | 47218 | 24.42 |
02:11 ET | 2658 | 24.425 |
02:13 ET | 3622 | 24.445 |
02:15 ET | 4407 | 24.45 |
02:18 ET | 6322 | 24.46 |
02:20 ET | 1730 | 24.45 |
02:22 ET | 100 | 24.455 |
02:24 ET | 3291 | 24.465 |
02:26 ET | 5473 | 24.47 |
02:27 ET | 1010 | 24.47 |
02:29 ET | 1725 | 24.48 |
02:31 ET | 2695 | 24.48 |
02:33 ET | 200 | 24.48 |
02:36 ET | 5595 | 24.48 |
02:38 ET | 8655 | 24.45 |
02:40 ET | 2126 | 24.43 |
02:42 ET | 2607 | 24.44 |
02:44 ET | 200 | 24.445 |
02:45 ET | 4685 | 24.465 |
02:47 ET | 2793 | 24.46 |
02:49 ET | 872 | 24.46 |
02:51 ET | 4329 | 24.475 |
02:54 ET | 322 | 24.475 |
02:56 ET | 2942 | 24.485 |
02:58 ET | 10539 | 24.495 |
03:00 ET | 67972 | 24.56 |
03:02 ET | 2023 | 24.505 |
03:03 ET | 6987 | 24.515 |
03:05 ET | 2156 | 24.5 |
03:07 ET | 3485 | 24.495 |
03:09 ET | 2648 | 24.52 |
03:12 ET | 3129 | 24.51 |
03:14 ET | 1072 | 24.5 |
03:16 ET | 3682 | 24.53 |
03:18 ET | 678 | 24.529 |
03:20 ET | 1531 | 24.515 |
03:21 ET | 7405 | 24.49 |
03:23 ET | 5063 | 24.525 |
03:25 ET | 841 | 24.525 |
03:27 ET | 772 | 24.525 |
03:30 ET | 4197 | 24.52 |
03:32 ET | 2073 | 24.51 |
03:34 ET | 2880 | 24.48 |
03:36 ET | 4050 | 24.48 |
03:38 ET | 8071 | 24.475 |
03:39 ET | 8402 | 24.47 |
03:41 ET | 2624 | 24.49 |
03:43 ET | 2147 | 24.48 |
03:45 ET | 2628 | 24.47 |
03:48 ET | 8069 | 24.475 |
03:50 ET | 2381 | 24.47 |
03:52 ET | 19578 | 24.495 |
03:54 ET | 9991 | 24.49 |
03:56 ET | 32666 | 24.45 |
03:57 ET | 23448 | 24.475 |
03:59 ET | 253187 | 24.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 7.0x | --- |
Exelixis Inc | 6.3B | 33.6x | -21.77% |
PTC Therapeutics Inc | 2.7B | -4.7x | --- |
P3 Health Partners Inc | 197.3M | -1.1x | --- |
Novavax Inc | 2.0B | -4.5x | --- |
Qiagen NV | 9.4B | 27.8x | +12.66% |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.44 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 7.0x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.